Azithramycine

Azithramycine is a lipid of Polyketides (PK) class. Azithramycine is associated with abnormalities such as Respiratory Tract Infections, Pneumonia, Lower respiratory tract infection, Infection and Nonspecific urethritis. The involved functions are known as Lysis, Selection, Genetic, Mutation, Relapse and Adaptation. Azithramycine often locates in Blood, Respiratory System, Genitourinary system, Back and Chest. The associated genes with Azithramycine are Genes, rRNA, Genome, RPL22 gene, OPRM1 gene and tryptic soy broth. The related lipids are Liposomes, Phosphatidylserines, Promega, Lipopolysaccharides and Steroids. The related experimental models are Mouse Model, Knock-out and Tissue Model.

Cross Reference

Introduction

To understand associated biological information of Azithramycine, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Azithramycine?

Azithramycine is suspected in Infection, Pneumonia, Trachoma, Respiratory Tract Infections, Gonorrhea, Infectious disease of lung and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Azithramycine

MeSH term MeSH ID Detail
Reproductive Tract Infections D060737 1 associated lipids
Chlamydial Pneumonia D061387 2 associated lipids
Pneumonia, Lipid D011017 2 associated lipids
Protozoan Infections D011528 6 associated lipids
Tick Bites D064927 1 associated lipids
Granulomatous Mastitis D058890 1 associated lipids
Per page 10 20 50 100 | Total 276

PubChem Associated disorders and diseases

What pathways are associated with Azithramycine

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Azithramycine?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Azithramycine?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Azithramycine?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Azithramycine?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Azithramycine?

Mouse Model

Mouse Model are used in the study 'Azithromycin increases in vitro fibronectin production through interactions between macrophages and fibroblasts stimulated with Pseudomonas aeruginosa.' (Cory TJ et al., 2013), Mouse Model are used in the study 'Efficacy of azithromycin, clarithromycin and beta-lactam agents against experimentally induced bronchopneumonia caused by Haemophilus influenzae in mice.' (Miyazaki S et al., 2001), Mouse Model are used in the study 'Oral anti-pneumococcal activity and pharmacokinetic profiling of a novel peptide deformylase inhibitor.' (Gross M et al., 2004), Mouse Model are used in the study 'Inhibition of quorum sensing in Pseudomonas aeruginosa by azithromycin and its effectiveness in urinary tract infections.' (Bala A et al., 2011) and Mouse Model are used in the study 'Enhanced efficacy of single-dose versus multi-dose azithromycin regimens in preclinical infection models.' (Girard D et al., 2005).

Knock-out

Knock-out are used in the study 'Influence of rhlR and lasR on Polymyxin Pharmacodynamics in Pseudomonas aeruginosa and Implications for Quorum Sensing Inhibition with Azithromycin.' (Bulman ZP et al., 2017) and Knock-out are used in the study 'Azithromycin in Pseudomonas aeruginosa biofilms: bactericidal activity and selection of nfxB mutants.' (Mulet X et al., 2009).

Tissue Model

Tissue Model are used in the study 'Development of a population pharmacokinetic model characterizing the tissue distribution of azithromycin in healthy subjects.' (Zheng S et al., 2014).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Azithramycine

Download all related citations
Per page 10 20 50 100 | Total 4404
Authors Title Published Journal PubMed Link
Desnica B et al. Myalgia and swelling of interphalangeal joints as side-effect of prolonged azithromycin therapy in patient with pelvic actinomycosis: case report. 2007 Scand. J. Infect. Dis. pmid:17366044
Dakdouki GK et al. Azithromycin-induced rash in infectious mononucleosis. 2002 Scand. J. Infect. Dis. pmid:12587634
Brihmer C et al. Efficacy and safety of azithromycin versus lymecyline in the treatment of genital chlamydial infections in women. 1996 Scand. J. Infect. Dis. pmid:8953672
Kuzman I et al. Azithromycin for treatment of community acquired pneumonia caused by Legionella pneumophila: a retrospective study. 1995 Scand. J. Infect. Dis. pmid:8588143
Schönwald S et al. Three-day azithromycin compared with ten-day roxithromycin treatment of atypical pneumonia. 1994 Scand. J. Infect. Dis. pmid:7747094
Brandén E et al. Intermittent azithromycin treatment for respiratory symptoms in patients with chronic Chlamydia pneumoniae infection. 2004 Scand. J. Infect. Dis. pmid:15764166
Nyström-Rosander C et al. Susceptibility of Chlamydia pneumoniae to azithromycin and doxycycline: methodological aspects on the determination of minimal inhibitory and minimal bactericidal concentrations. 1997 Scand. J. Infect. Dis. pmid:9435043
Colakoglu S et al. Prevalence and mechanisms of macrolide resistance in Streptococcus pyogenes in Ankara, Turkey. 2006 Scand. J. Infect. Dis. pmid:16798693
Müller S et al. Resistance to ampicillin, third-generation cephalosporins, ciprofloxacin, co-trimoxazole and azithromycin in clinical isolates of Salmonella enterica subsp. enterica from Germany: real problem or sporadic circumstance? 2011 Scand. J. Infect. Dis. pmid:21265586
Chini P et al. Effect of azithromycin on small bowel motility in patients with gastrointestinal dysmotility. 2012 Scand. J. Gastroenterol. pmid:22364597
Tabbara KF et al. Azithromycin prophylaxis and treatment of murine toxoplasmosis. 2005 Saudi Med J pmid:15806206
Vafaeimanesh J et al. Expression comparison of azithromycin and clarithromycin in triple-therapy regimens for eradication of Helicobacter pylori in hemodialysis patients. 2014 Saudi J Kidney Dis Transpl pmid:24434382
Agah S et al. Comparison of azithromycin and metronidazole in a quadruple-therapy regimen for Helicobacter pylori eradication in dyspepsia. 2009 Oct-Dec Saudi J Gastroenterol pmid:19794266
Drake WP et al. Effects of broad-spectrum antimycobacterial therapy on chronic pulmonary sarcoidosis. 2013 Sarcoidosis Vasc Diffuse Lung Dis pmid:24284293
Elias AF et al. Typhoid fever in a young immigrant child: a case report and review of the literature. 2008 S D Med pmid:18717293
Gologan R et al. Multiple myeloma in remission complicated by bone marrow granulomas. 2003 Rom J Intern Med pmid:15526516
Toledo Junior A et al. Poor response to azithromycin in cutaneous leishmaniasis leading to a premature interruption of a multicentric phase III clinical trial in Brazil. 2014 Nov-Dec Rev. Soc. Bras. Med. Trop. pmid:25626655
Gakiya E et al. [Experimental infection in mice by Plasmodium berghei: an evidence of antiparasitic action of azithromycin]. 2001 Mar-Apr Rev. Soc. Bras. Med. Trop. pmid:11391444
Braz LM et al. [The evaluation of the efficacy of azithromycin and pyrimethamine used alone or in combination in the treatment of an experimental infection in mice by Toxoplasma gondii]. 1999 Jul-Aug Rev. Soc. Bras. Med. Trop. pmid:10495670
Sinagra A et al. The activity of azithromycin against Leishmania (Viannia) braziliensis and Leishmania (Leishmania) amazonensis in the golden hamster model. 2007 Nov-Dec Rev. Soc. Bras. Med. Trop. pmid:18200413
Lescano SA et al. [Evaluation of the efficacy of azithromycin and pyrimethamine, for treatment of experimental infection of mice with Toxoplasma gondii cystogenic strain]. 2004 Nov-Dec Rev. Soc. Bras. Med. Trop. pmid:15765594
Prata A et al. Efficacy of azithromycin in the treatment of cutaneous leishmaniasis. 2003 Jan-Feb Rev. Soc. Bras. Med. Trop. pmid:12715065
Silva-Vergara ML et al. Azithromycin in the treatment of mucosal leishmaniasis. 2004 May-Jun Rev. Inst. Med. Trop. Sao Paulo pmid:15286825
Teixeira AC et al. Low efficacy of azithromycin to treat cutaneous leishmaniasis in Manaus, AM, Brazil. 2007 Jul-Aug Rev. Inst. Med. Trop. Sao Paulo pmid:17823753
Teixeira AC et al. Failure of both azithromycin and antimony to treat cutaneous leishmaniasis in Manaus, AM, Brazil. 2008 May-Jun Rev. Inst. Med. Trop. Sao Paulo pmid:18604416
Faucher P and Madelenat P [Induced abortion]. 2006 Rev Prat pmid:17139871
Vaz AP et al. [Azithromycin as an adjuvant therapy in cryptogenic organizing pneumonia]. 2011 Jul-Aug Rev Port Pneumol pmid:21652172
Santos N et al. QT interval prolongation and extreme bradycardia after a single dose of azithromycin. 2010 Rev Port Cardiol pmid:20391905
Bedos JP and Veber B [Lower respiratory infections: predictive factors of therapeutic response]. 1996 Rev Pneumol Clin pmid:9033917
Zuck P [Efficacy of a 5-day treatment with an azalide (azithromycin) in superinfections of chronic bronchitis]. 1996 Rev Pneumol Clin pmid:9033919
Díaz Sánchez M et al. [New medications: azithromycin]. 1993 Jul-Sep Rev Med Univ Navarra pmid:8134755
Baumgartner JD and Christin L [2011 news in infections diseases: selected readings]. 2012 Rev Med Suisse pmid:22303737
Diezi L et al. [Pharmacovigilance update]. 2014 Rev Med Suisse pmid:24558915
Widikker I and Rochat T [Pulmonary medicine. Four major papers in 2010-2011]. 2012 Rev Med Suisse pmid:23185822
Scheen AJ [Pharma-clinics. Drug of the month. Azithromycin (Zitromax)]. 1995 Rev Med Liege pmid:7481274
Sasseigne G et al. [Fever and abdominal pain in a 56-year-old woman]. 2009 Rev Med Interne pmid:19815317
Diculencu D et al. [The postantibiotic effect of azithromycin on respiratory pathogens]. 1998 Jul-Dec Rev Med Chir Soc Med Nat Iasi pmid:10756861
Diculencu D et al. [The postantibiotic effect of azithromycin on respiratory pathogens]. 1996 Jul-Dec Rev Med Chir Soc Med Nat Iasi pmid:9455450
Eymin G et al. [Cat-scratch disease. Review of eight adult patients hospitalized for fever or adenopathy]. 2006 Rev Med Chil pmid:17186093
Flores S et al. [Triple therapy of short-term with azithromycin, amoxycillin and omeprazole for the eradication of Helicobacter pylori]. 2000 Rev Med Chil pmid:11008354
Uribe P et al. [Bacillary angiomatosis]. 2012 Rev Med Chil pmid:23282705
Abely M et al. [National consensus regarding azithromycin use in cystic fibrosis]. 2015 Rev Mal Respir pmid:26003196
Silva FM et al. Low efficacy of an ultra-short term, once-daily dose triple therapy with omeprazole, azithromycin, and secnidazole for Helicobacter pylori eradication in peptic ulcer. 2002 Jan-Feb Rev Hosp Clin Fac Med Sao Paulo pmid:12170343
López-Fabal F et al. [In vitro activities of colistin combinations against Pseudomonas aeruginosa isolated from the intensive care unit]. 2008 Rev Esp Quimioter pmid:18792821
Alvarez MP et al. [Pharmacovigilance study of azithromycin tablets (500 mg) in the treatment of adult patients with respiratory tract infections]. 2000 Rev Esp Quimioter pmid:11086281
Toro C et al. [Prevalence of primary Helicobacter pylori resistance to eight antimicrobial agents in a hospital in Madrid]. 2001 Rev Esp Quimioter pmid:11704771
Gómez J et al. [Prospective, comparative study (1994-1998) of the influence of short-term prophylactic treatment with azithromycin on patients with advanced COPD]. 2000 Rev Esp Quimioter pmid:11498704
Fernández Cuenca F et al. [In vitro activity of azithromycin against clinical isolates of Acinetobacter baumannii]. 2003 Rev Esp Quimioter pmid:12973458
Calvo A et al. [Activity of different antimicrobial agents against penicillin-resistant Streptococcus pneumoniae]. 2001 Rev Esp Quimioter pmid:11856980
Sánchez F et al. [Treatment of pneumonia caused by Legionella with azithromycin]. 1998 Rev Esp Quimioter pmid:9795300